Analysts' Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), LAVA Therapeutics (LVTX) and Aura Biosciences Inc (AURA)
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Generation Bio (GBIO)
Wedbush: Reiterates the Generation Bio (GBIO.US) rating and adjusted from superior to superior market rating, with a target price of $5.00.
Generation Bio Analyst Ratings
Wedbush Remains a Buy on Generation Bio (GBIO)
Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Generation Bio (GBIO)
Analysts Are Bullish on These Healthcare Stocks: Generation Bio (GBIO), Poseida Therapeutics (PSTX)
Needham: Reiterates Generation Bio (GBIO.US) rating and adjusted from buy to buy rating, target price is $10.00.
Generation Bio Analyst Ratings
Needham Reiterates Buy on Generation Bio, Maintains $10 Price Target
Wedbush Reiterates Outperform on Generation Bio, Maintains $5 Price Target
Analysts' Top Healthcare Picks: Generation Bio (GBIO), Curaleaf Holdings (CURLF)
Generation Bio Analyst Ratings
Needham Maintains Buy on Generation Bio, Lowers Price Target to $10
JMP Securities Keeps Their Hold Rating on Generation Bio (GBIO)
Analysts Conflicted on These Healthcare Names: Generation Bio (GBIO), RegenXBio (RGNX) and Halozyme (HALO)
Analysts' Top Healthcare Picks: Ardelyx (ARDX), Generation Bio (GBIO)
JMP Securities Keeps Their Hold Rating on Generation Bio (GBIO)
Wedbush Adjusts Generation Bio Price Target to $5 From $9, Maintains Outperform Rating
Analyst Upholds Buy Rating for Generation Bio Based on 3Q23 Earnings and Strong Financial Health
No Data